Document Type : Original Article
Authors
- Siavash Abdi Gheshlaghi 1
- Zahra Babaeinejad 1
- Mehrzad Saraei 2
- Navid Mohammadi 3
- Elham Hajialilo 2
- Amir Javadi 4
- Peyman Heydarian 5
- Fatemeh Samieerad 6
1 Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
2 Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran & Department of Medical Parasitology and Mycology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
3 Children Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran & Researcher, Canada Optimax Access Consultation, Ottawa, Canada
4 Department of Community Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
5 Department of Medical Parasitology and Mycology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran & Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
6 Department of Pathology, Qazvin University of Medical Sciences, Qazvin, Iran
Abstract
Background: The present study was designed to determine the prevalence of Toxoplasma gondii seronegative pregnant women, estimate the frequency of fetuses at risk of congenital toxoplasmosis in the study area, and also to investigate the awareness of the studied mothers about T. gondii disease.
Methods: A total of 740 pregnant women referred to two health centers in Qazvin province were surveyed voluntarily for anti-T. gondii IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA). IgG avidity test was used as a confirmatory test for samples showing positive or borderline results for IgM antibodies. Data on socioeconomic, demographic, and knowledge of participants about toxoplasmosis were collected using questionnaires and through face-to-face interviews. Multivariable logistic regression modeling was used to identify the potential predictor variables for T. gondii infection.
Results: Overall, 21.2% (157/740) and 0.27% (2/740) of pregnant women were positive for T. gondii IgG and IgM antibodies, respectively. Only 1.7% (13/740) of expectant mothers had prior information on toxoplasmosis. Among socioeconomic and demographic variables, contact with soil was the merely cause of a significant association with T. gondii infection. Other variables including age, occupation, education level, residential area, source of drinking water, abortion history, number of childbirth, consumption of raw/undercooked meat, having home cat and and consumption of raw vegetables failed to establish significant associations.
Conclusion: Our results clarified that the prevalence of T. gondii has remarkably reduced in the study area. This finding indicates a low risk of congenital toxoplasmosis in this region.
Keywords
CRC Press; 2010. p. 313.
2. Andiappan H, Nissapatorn V, Sawangjaroen N, Chemoh W,
Lau YL, Kumar T, et al. Toxoplasma infection in pregnant
women: a current status in Songklanagarind hospital, southern
Thailand. Parasit Vectors. 2014;7:239. doi: 10.1186/1756-
3305-7-239.
3. Bamba S, Cissé M, Sangaré I, Zida A, Ouattara S, Guiguemdé
RT. Seroprevalence and risk factors of Toxoplasma gondii
infection in pregnant women from Bobo Dioulasso, Burkina
Faso. BMC Infect Dis. 2017;17(1):482. doi: 10.1186/s12879-
017-2583-6.
4. Dentico P, Volpe A, Putoto G, Ramadani N, Bertinato L,
Berisha M, et al. Toxoplasmosis in Kosovo pregnant women.
New Microbiol. 2011;34(2):203-207.
5. Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of
toxoplasmosis and risk factors of Toxoplasma gondii infection
among pregnant women in Sri Lanka: a cross sectional study.
BMC Public Health. 2017;17(1):930. doi: 10.1186/s12889-
017-4941-0.
6. Lobo ML, Patrocinio G, Sevivas T, De Sousa B, Matos
O. Portugal and Angola: similarities and differences in
Toxoplasma gondii seroprevalence and risk factors in pregnant
Abdi Gheshlaghi et al
434 Journal of Kerman University of Medical Sciences. Volume 29, Number 5, 2022
women. Epidemiol Infect. 2017;145(1):30-40. doi: 10.1017/
S0950268816001904.
7. Mwambe B, Mshana SE, Kidenya BR, Massinde AN, Mazigo
HD, Michael D, et al. Sero-prevalence and factors associated
with Toxoplasma gondii infection among pregnant women
attending antenatal care in Mwanza, Tanzania. Parasit Vectors.
2013;6:222. doi: 10.1186/1756-3305-6-222.
8. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and
Bennett’s Principles and Practice of Infectious Diseases. 7th
ed. Elsevier Health Sciences; 2010. p. 2265.
9. Smit GSA, Vu TLB, Do TD, Speybroeck N, Devleesschauwer
B, Padalko E, Roets E, Dorny P. Prenatal diagnosis and
prevention of toxoplasmosis in pregnant women in Northern
Vietnam: study protocol. BMC Infect Dis. 2017;17(1):364.
doi: 10.1186/s12879-017-2446-1.
10. Berghold C, Herzog SA, Jakse H, Berghold A. Prevalence
and incidence of toxoplasmosis: a retrospective analysis of
mother-child examinations, Styria, Austria, 1995 to 2012.
Euro Surveill. 2016;21(33):30317. doi: 10.2807/1560-7917.
ES.2016.21.33.30317.
11. Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S,
Kakinoki S, Nakata M, Yasuda T, Ikenoue T, Kojima T. AntiToxoplasma antibody prevalence, primary infection rate, and
risk factors in a study of toxoplasmosis in 4,466 pregnant
women in Japan. Clin Vaccine Immunol. 2012;19(3):365-7.
doi: 10.1128/CVI.05486-11.
12. Rocha ÉM, Lopes CW, Ramos RA, Alves LC. Risk factors for
Toxoplasma gondii infection among pregnant women from the
State of Tocantins, Northern Brazil. Rev Soc Bras Med Trop.
2015;48(6):773-5. doi: 10.1590/0037-8682-0074-2015.
13. Ferguson W, Mayne PD, Cafferkey M, Butler K. Lack of
awareness of risk factors for primary toxoplasmosis in
pregnancy. Ir J Med Sci. 2011;180(4):807-11. doi: 10.1007/
s11845-011-0723-3.
14. Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A,
Schulkin J, Lynfield R. Toxoplasmosis-related knowledge
and practices among pregnant women in the United
States. Infect Dis Obstet Gynecol. 2003;11(3):139-45. doi:
10.1080/10647440300025512.
15. Li X, Xu T, Song R. Awareness and infection of Toxoplasma
gondii in married childbearing women in Chengde
Region. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi.
2014;26(4):475-6. [Chinese].
16. Millar PR, Moura FL, Bastos OM, Mattos DP, Fonseca AB,
Sudré AP, Leles D, Amendoeira MR. Toxoplasmosis-related
knowledge among pregnant and postpartum women attended
in public health units in Niterói, Rio De Janeiro, Brazil. Rev
Inst Med Trop Sao Paulo. 2014;56(5):433-8. doi: 10.1590/
s0036-46652014000500011.
17. Morioka I, Sonoyama A, Tairaku S, Ebina Y, Nagamata S,
Morizane M, et al. Awareness of and knowledge about
mother‐to‐child infections in J apanese pregnant women.
Congenital Anomalies. 2014;54(1):35-40.
18. Ying W, Wen-Li Y. Prevalence and awareness of Toxoplasma
gondii of pregnant women in Bazhou City, Hebei Province.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016;28(3):340-
342. [Chinese]. doi: 10.16250/j.32.1374.2015212.
19. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology
of toxoplasmosis in primigravida women in Hamadan,
Islamic Republic of Iran, 2004. East Mediterr Health J.
2008;14(1):163-71.
20. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S,
Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii
in the Iranian pregnant women: A systematic review and
meta-analysis. Acta Trop. 2016;158:160-169. doi: 10.1016/j.
actatropica.2016.03.003.
21. Ghasemloo H, Ghomashlooyan M, Hooshyar H.
Seroprevalence of Toxoplasma gondii infection among
pregnant women admitted at Shahid Akbar Abadi hospital,
Tehran, Iran, 2010-2013. J Med Microbiol Infect Dis.
2014;2(1):16-8.
22. Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri
A, Rahimi MT, Hosseini SA, Daryani A. Toxoplasmosis
seroprevalence in Iranian women and risk factors of the
disease: a systematic review and meta-analysis. Trop Med
Health. 2017;45:7. doi: 10.1186/s41182-017-0048-7.
23. Sharbatkhori M, Dadi Moghaddam Y, Pagheh AS, Mohammadi
R, Hedayat Mofidi H, Shojaee S. Seroprevalence of
Toxoplasma gondii Infections in Pregnant Women in Gorgan
City, Golestan Province, Northern Iran-2012. Iran J Parasitol.
2014;9(2):181-7.
24. Saffar M, Ajami A. Prevalence of Toxoplasma gondi in
pregnancy in Sari 1376-1377. Journal of Mazandaran
University of Medical Sciences. 1999;9(24):1-5.
25. Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii
in unmarried women in Qazvin, Islamic Republic of Iran. East
Mediterr Health J. 2010;16(1):24-8.
26. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri
A, Rahimi MT, Sharif M. Seroprevalence of Toxoplasma gondii
in the Iranian general population: a systematic review and
meta-analysis. Acta Trop. 2014;137:185-94. doi: 10.1016/j.
actatropica.2014.05.015.
27. Abamecha F, Awel H. Seroprevalence and risk factors of
Toxoplasma gondii infection in pregnant women following
antenatal care at Mizan Aman General Hospital, Bench Maji
Zone (BMZ), Ethiopia. BMC Infect Dis. 2016;16(1):460. doi:
10.1186/s12879-016-1806-6.
28. Paul E, Kiwelu I, Mmbaga B, Nazareth R, Sabuni E, Maro
A, et al. Toxoplasma gondii seroprevalence among pregnant
women attending antenatal clinic in Northern Tanzania.
Tropical medicine and health. 2018;46:39. doi: 10.1186/
s41182-018-0122-9.
29. Oliveira GMS, Simões JM, Schaer RE, Freire SM, Nascimento
RJM, Pinheiro AMCM, Carvalho SMS, Mariano APM,
Carvalho RC, Munhoz AD. Frequency and factors associated
with Toxoplasma gondii infection in pregnant women and
their pets in Ilhéus, Bahia, Brazil. Rev Soc Bras Med Trop.
2019;52:e20190250. doi: 10.1590/0037-8682-0250-2019.
30. Mosawi SH, Zarghona Z, Dalimi A, Jokelainen P, Safa
AH, Mohammadi MR, et al. Particularly neglected in
countries with other challenges: High Toxoplasma gondii
seroprevalence in pregnant women in Kabul, Afghanistan,
while a low proportion know about the parasite. PloS One.
2019;14(10):e0223585. doi: 10.1371/journal.pone.0223585.
31. Sharifdini M, Ghanbarzadeh L, Barikani A, Saraei M.
Prevalence of intestinal parasites among rural inhabitants of
Fouman, Guilan Province, Northern Iran with emphasis on
Strongyloides stercoralis. Iran J Parasitol. 2020;15(1):91-100.
32. Taherkhani K, Barikani A, Shahnazi M, Saraei M. Prevalence
of intestinal parasites among rural residents of Takestan in
North-West of Iran. Iran J Parasitol. 2019;14(4):657.
33. Babaie J, Amiri S, Mostafavi E, Hassan N, Lotfi P, Esmaeili
Rastaghi AR, et al. Seroprevalence and risk factors for
Toxoplasma gondii infection among pregnant women in
Northeast Iran. Clin Vaccine Immunol. 2013;20(11):1771-3.
doi: 10.1128/CVI.00125-13.
34. Cong W, Dong X-Y, Meng Q-F, Zhou N, Wang X-Y,
Huang S-Y, et al. Toxoplasma gondii infection in pregnant
women: a seroprevalence and case-control study in
Eastern China. Biomed Res Int. 2015;2015:170278. doi:
10.1155/2015/170278.
35. Kamal AM, Ahmed AK, Abdellatif MZ, Tawfik M, Hassan
Journal of Kerman University of Medical Sciences. Volume 29, Number 5, 2022 435
Serological screening for congenital toxoplasmosis during pregnancy
EE. Seropositivity of toxoplasmosis in pregnant women by
ELISA at Minia University Hospital, Egypt. Korean J Parasitol.
2015;53(5):605-10. doi: 10.3347/kjp.2015.53.5.605.
36. Hung C-S, Su H-W, Lee Y-L, Weng H-W, Wang Y-C, Naito
T, et al. Seroprevalence, seroconversion, and risk factors for
toxoplasmosis among pregnant women in Taipei, Taiwan.
Jpn J Infect Dis. 2015;68(4):312-7. doi: 10.7883/yoken.
JJID.2014.263.
37. Khademi SZ, Ghaffarifar F, Dalimi A, Davoodian P, Abdoli
A. Prevalence and risk factors of toxoplasma gondii infection
among pregnant women in Hormozgan Province, south of
Iran. Iran J Parasitol. 2019;14(1):167.
38. Sroka S, Bartelheimer N, Winter A, Heukelbach J, Ariza L,
Ribeiro H, Oliveira FA, Queiroz AJ, Alencar C Jr, Liesenfeld O.
Prevalence and risk factors of toxoplasmosis among pregnant
women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg.
2010;83(3):528-33. doi: 10.4269/ajtmh.2010.10-0082.
39. Smereka J, Szarpak L, Ruetzler K, Schacham Y, Smereka A,
Dabrowski M, et al. A multicenter survey on toxoplasmosis
knowledge among pregnant women in Poland (the TOWER
study). BMC Pregnancy Childbirth. 2018;18(1):389. doi:
10.1186/s12884-018-2031-7.
)